GreatNorthCollective/greatnorth-canada-federal-laws-text huggingface dataset:
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
( name of applicant ) for export to ( name of WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of applicant ) hereby declares, in accordance with clause 21.04(3)(d)(i)(A) of the Act, that the pharmaceutical product to which the application relates (a) is the pharmaceutical product specified in the notice in writing that the WTO Member has provided to the TRIPS Council; and (b) is not patented in that WTO Member.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
(a) is the pharmaceutical product specified in the notice in writing that the WTO Member has provided to the TRIPS Council; and
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
( name of WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of applicant ) hereby declares, in accordance with clause 21.04(3)(d)(i)(B) of the Act, that the pharmaceutical product to which the application relates is the pharmaceutical product that is specified in the notice in writing that the WTO Member has provided to the TRIPS Council.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
In the matter of an application by ( name of applicant ) for export to ( name of country ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
( name of country ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of applicant ) hereby declares, in accordance with clause 21.04(3)(d)(ii)(A) of the Act, that the pharmaceutical product to which the application relates (a) is the pharmaceutical product specified in the notice in writing that the country has provided to the Government of Canada; and (b) is not patented in that country.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
(a) is the pharmaceutical product specified in the notice in writing that the country has provided to the Government of Canada; and
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of applicant ) declares, in accordance with clause 21.04(3)(d)(ii)(B) of the Act, that the pharmaceutical product to which the application relates is the pharmaceutical product that is specified in the notice in writing that the country has provided to the Government of Canada.
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of applicant ) hereby declares, in accordance with clause 21.04(3)(d)(iii)(A), (iv)(A) or (v)(A) of the Act, as the case may be, that the pharmaceutical product to which the application relates is not patented in the country or WTO Member.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
In the matter of authorization number granted on ( date ) to ( name of holder of authorization ) for export to ( name of country or WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned ( name of holder of authorization ) hereby declares, in accordance with paragraph 21.16(1)(b) of the Act, that (a) the total monetary value of the agreement, expressed in Canadian currency, as it relates to the pharmaceutical product authorized to be manufactured and sold is $ ; and (b) the number of units of the pharmaceutical product to be sold under the terms of the agreement is .
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
(a) the total monetary value of the agreement, expressed in Canadian currency, as it relates to the pharmaceutical product authorized to be manufactured and sold is $ ; and
Use of Patented Products for International Humanitarian Purposes Regulations — (b)
(b) the number of units of the pharmaceutical product to be sold under the terms of the agreement is .
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
In the matter of application for authorization number by ( name of applicant ) for export to ( name of country or WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 I hereby authorize ( name of applicant ), whose postal address is , to make, construct and use, the patented invention(s) identified in patent number(s) solely for purposes directly related to the manufacture of the above-mentioned pharmaceutical product, and to sell it for export to the above-mentioned country or WTO Member.
Use of Patented Products for International Humanitarian Purposes Regulations — 2
2 The quantity of the pharmaceutical product authorized to be manufactured by this authorization is .
Use of Patented Products for International Humanitarian Purposes Regulations — 3
3 In accordance with section 21.09 of the Act, this authorization is valid for a period of two years beginning on the date shown below.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
In the matter of an application for renewal of authorization by ( name of applicant ) for export to ( name of country or WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — 1
1 The undersigned, whose postal address and telephone number are , hereby applies for a renewal of authorization number that was granted on ( date ) authorizing the making, construction and use of the patented invention(s) identified in the patent numbers below, solely for purposes directly related to the manufacture of ( unexported quantity ) of the above-mentioned pharmaceutical product and its sale for export to the above-mentioned country or WTO Member.
Use of Patented Products for International Humanitarian Purposes Regulations — Use of Patented Products for International Humanitarian Purposes Regulations
, hereby applies for a renewal of authorization number that was granted on ( date ) authorizing the making, construction and use of the patented invention(s) identified in the patent numbers below, solely for purposes directly related to the manufacture of ( unexported quantity ) of the above-mentioned pharmaceutical product and its sale for export to the above-mentioned country or WTO Member.
Use of Patented Products for International Humanitarian Purposes Regulations — 2
2 For each patented invention to which the application for renewal relates, the name(s) of the patentee(s) of the invention, the name(s) and postal address(es) of the representative(s) of the patentee(s) or, if no representative has been appointed, the postal address(es) of the patentee(s), and the patent number(s) issued in respect of the invention are as follows: Name of Patentee Name and Address of Patentee’s Representative or Address of Patentee Patent Number (a) (b) (c) (d)
Use of Patented Products for International Humanitarian Purposes Regulations — 3
3 The undersigned hereby certifies that (a) the quantities of the pharmaceutical product that were authorized under authorization number to be manufactured and sold for export under section 21.04 of the Act were not or will not have been exported before the authorization ceases to be valid; and (b) the undersigned has complied with the terms of the authorization and the requirements of sections 21.06 to 21.08 of the Act.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
(a) the quantities of the pharmaceutical product that were authorized under authorization number to be manufactured and sold for export under section 21.04 of the Act were not or will not have been exported before the authorization ceases to be valid; and
Use of Patented Products for International Humanitarian Purposes Regulations — (b)
(b) the undersigned has complied with the terms of the authorization and the requirements of sections 21.06 to 21.08 of the Act.
Use of Patented Products for International Humanitarian Purposes Regulations — (a)
In the matter of an application for a renewal of an authorization by ( name of applicant ) for export to ( name of country or WTO Member ) of the following pharmaceutical product: (a) if the pharmaceutical product is a drug as defined in section 2 of the Food and Drugs Act : ( name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product ); or (b) if the pharmaceutical product is a medical device: ( name of the pharmaceutical product as set out in Schedule 1 to the Act, its class, and its identifier within the meaning of section 1 of the Medical Devices Regulations );
Use of Patented Products for International Humanitarian Purposes Regulations — Use of Patented Products for International Humanitarian Purposes Regulations
And in the matter of authorization number that was granted in accordance with section 21.04 of the Act on ( date ) to make, construct and use the patented invention(s) identified in patent number(s) solely for purposes directly related to the manufacture of the quantity remaining to be shipped ( quantity ) of the above-mentioned pharmaceutical product, and to sell it for export to ( name of country or WTO Member );
Use of Patented Products for International Humanitarian Purposes Regulations — Use of Patented Products for International Humanitarian Purposes Regulations
And whereas the applicant has not yet manufactured and exported the above-noted quantity of the pharmaceutical product on the date of its application for renewal;
Use of Patented Products for International Humanitarian Purposes Regulations — Use of Patented Products for International Humanitarian Purposes Regulations
I hereby renew the above-mentioned authorization in accordance with section 21.12 of the Act.
Canada Education Savings Regulations — a
Her Excellency the Governor General in Council, on the recommendation of the Minister of State styled Minister of Human Resources and Skills Development, pursuant to section 13 of the Canada Education Savings Act a , hereby makes the annexed Canada Education Savings Regulations . a S.C. 2004, c. 26
Canada Education Savings Regulations — 1
1 The definitions in this section apply in these Regulations. Act means the Canada Education Savings Act . ( Loi ) assisted contribution means a contribution made to an RESP in respect of which a CES grant has been paid. ( cotisation subventionnée ) brother in relation to a beneficiary, includes a son of the common-law partner or spouse of a parent of the beneficiary. ( frère ) CLB means Canada Learning Bond. ( Version anglaise seulement ) CLB account means an account that holds the CLB paid into an RESP in respect of a beneficiary. ( compte du bon d’études ) common-law partner has the same meaning as in subsection 248(1) of the Income Tax Act . ( conjoint de fait ) EAP means an educational assistance payment. ( PAE ) grant account means an account that holds all CES grants paid into an RESP. ( compte de subvention ) RESP means a registered education savings plan. ( REEE ) sister in relation to a beneficiary, includes a daughter of the common-law partner or spouse of a parent of the beneficiary. ( sœur ) trustee agreement means an agreement entered into by the Minister and a trustee under an RESP that relates to the payment of a CES grant or CLB to the RESP. ( convention de fiducie )
Canada Education Savings Regulations — Canada Education Savings Regulations
Act means the Canada Education Savings Act . ( Loi )
Canada Education Savings Regulations — Canada Education Savings Regulations
assisted contribution means a contribution made to an RESP in respect of which a CES grant has been paid. ( cotisation subventionnée )
Canada Education Savings Regulations — Canada Education Savings Regulations
brother in relation to a beneficiary, includes a son of the common-law partner or spouse of a parent of the beneficiary. ( frère )
Canada Education Savings Regulations — Canada Education Savings Regulations
CLB means Canada Learning Bond. ( Version anglaise seulement )
Canada Education Savings Regulations — Canada Education Savings Regulations
CLB account means an account that holds the CLB paid into an RESP in respect of a beneficiary. ( compte du bon d’études )
Canada Education Savings Regulations — Canada Education Savings Regulations
common-law partner has the same meaning as in subsection 248(1) of the Income Tax Act . ( conjoint de fait )
Canada Education Savings Regulations — Canada Education Savings Regulations
EAP means an educational assistance payment. ( PAE )
Canada Education Savings Regulations — Canada Education Savings Regulations
grant account means an account that holds all CES grants paid into an RESP. ( compte de subvention )
Canada Education Savings Regulations — Canada Education Savings Regulations
RESP means a registered education savings plan. ( REEE )
Canada Education Savings Regulations — Canada Education Savings Regulations
sister in relation to a beneficiary, includes a daughter of the common-law partner or spouse of a parent of the beneficiary. ( sœur )
Canada Education Savings Regulations — Canada Education Savings Regulations
trustee agreement means an agreement entered into by the Minister and a trustee under an RESP that relates to the payment of a CES grant or CLB to the RESP. ( convention de fiducie )
Canada Education Savings Regulations — 2
2 If both assisted and unassisted contributions have been made to an RESP, withdrawals of contributions from the RESP are considered to be made in the order specified below: (a) assisted contributions are considered to be withdrawn before unassisted contributions; and (b) unassisted contributions made after 1997 are considered to be withdrawn before unassisted contributions made before 1998.
Canada Education Savings Regulations — 3
3 When a contribution has been made in a particular year and a CES grant in respect of the contribution would otherwise be payable at a time in a year following the particular year, the CES grant shall be reduced by the total of all amounts each of which is, in respect of another CES grant paid after the particular year and before that time, the amount by which the other CES grant would have been reduced had the CES grant been paid in the particular year.
Canada Education Savings Regulations — 5
5 (1) For the purposes of paragraph 5(3)(b) of the Act and paragraph 4(1)(f) of these Regulations, if contributions that were made to an RESP before 1998 are withdrawn from the RESP after February 23, 1998, any individual who is a beneficiary of the RESP at any time during the period beginning on February 24, 1998 and ending on the day of the withdrawal is an ineligible beneficiary throughout the period that begins on the day of the withdrawal and ends on the last day of the second year following the year in which the withdrawal is made. (2) Subsection (1) does not apply if (a) the total of all withdrawals made under the RESP for the year does not exceed $200; (b) the withdrawal is made at a time when at least one beneficiary under the RESP is eligible to receive an EAP under the RESP; (c) the withdrawal is an eligible transfer; or (d) the withdrawal is all or part of an excess amount of contributions to reduce the amount of tax, otherwise payable under Part X.4 of the Income Tax Act , and, at the time of the withdrawal, the excess amount for the year is not greater than $4,000.
Canada Education Savings Regulations — 6
6 (1) The Minister may pay a CLB if (a) the trustee enters into a trustee agreement with the Minister that applies to the RESP and includes the terms and conditions set out in section 8; (b) the application for the CLB is made by the trustee, at the request of a subscriber under the RESP; (c) the RESP complies at the time of the CLB payment with the conditions for registration set out in subsection 146.1(2) of the Income Tax Act that apply in respect of education savings plans entered into on January 1, 1999; (d) the RESP has only one beneficiary or, if there is more than one, every beneficiary is a brother or sister of every other beneficiary; (e) the RESP has a CLB account for each beneficiary in respect of whom a CLB is paid; and (f) the trustee complies with the terms and conditions of these Regulations and the trustee agreement that applies to the RESP. (2) At the time a CLB is paid to an RESP, the trustee shall credit the beneficiary’s CLB account within the RESP with the amount of the CLB paid. SOR/2018-275, s. 3
Canada Education Savings Regulations — 7
7 The Minister may, for the purposes of section 9.1 of the Act, waive the requirement (a) to designate a trust under subsection 5(7) of the Act; (b) to apply for a CLB before the beneficiary reaches 21 years of age under subsection 6(1) of the Act; (c) to designate a trust under subsection 6(4) of the Act; (d) to provide a Social Insurance Number or business number under paragraph 7(b) of the Act; and (e) to apply for CES grants within the time limits set out in paragraph 4(1)(b).
Canada Education Savings Regulations — 8
8 Every trustee agreement shall include the following terms and conditions: (a) the trustee shall provide the Minister with any information that the Minister requires for the purposes of the Act and these Regulations; (b) the trustee shall maintain records and books of account that relate to the amounts paid under the Act in such form and containing such information as the Minister requires to enable the Minister to determine whether the amounts will be paid or are required to be repaid; (c) the trustee shall allow the Minister access to all documents and other information that the Minister requires for auditing payments or repayments made under the Act or these Regulations; (d) the trustee shall report to the Minister (i) all contributions and transfers to, and all withdrawals and transfers from, an RESP that are made after 1997, (ii) the portion of EAPs made from the RESP that is attributable to amounts paid under the Act, and (iii) any other information related to the RESP that is specified in the trustee agreement; (e) the reporting referred to in paragraph (d) shall be done annually or within any shorter period that is set out in the trustee agreement; (f) the trustee shall submit all information to the Minister in a format and manner that is acceptable to the Minister; (g) the trustee may make a distribution from an RESP only if, at the time immediately after the distribution, the fair market value of the property held in connection with the RESP would not be less than the total of the balance in the grant account and all CLB accounts of the RESP, unless the distribution is an EAP made to a beneficiary of the RESP and all of the EAP is attributable to CES grants and to a CLB; (h) the trustee shall repay any amount required to be repaid to the Minister under these Regulations, other than the amounts payable by a beneficiary under subsection 12(2) and section 13; and (i) the trustee shall not charge fees related to the RESP against the balance of the grant account or the CLB account of any beneficiary of the RESP.
Canada Education Savings Regulations — 9
9 Every agreement between the Minister and the promoter of an RESP shall include the following terms and conditions: (a) the promoter shall provide the trustee with any information that the Minister requires for the purposes of the Act and these Regulations; (b) the promoter shall report to the Minister any information related to the RESP that is specified in the agreement; (c) the promoter shall submit all information to the Minister in a format and manner that is acceptable to the Minister; (d) the promoter shall allow the Minister access to all documents and other information related to RESPs that the Minister requires for audit purposes; and (e) the promoter shall not charge fees related to the RESP against the balance of the grant account or the CLB account of any beneficiary in the RESP.